SELLAS Life Sciences Group annual gross profit
2011
2012
2013
2014
2020
2021
2022
2023
SELLAS Life Sciences Group Gross Profit Growth & History (SLS)
SELLAS Life Sciences Group's gross profit was $0 for fiscal 2023.
View full SELLAS Life Sciences Group company overviewSELLAS Life Sciences Group annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | $0 | −$900,000 | — |
| 2022 | 2022-12-31 | $900,000 | −$6.5M | −87.84% |
| 2021 | 2021-12-31 | $7.4M | $5.5M | +289.47% |
| 2020 | 2020-12-31 | $1.9M | — | — |
| 2014 | 2014-12-31 | $7.9M | $5.9M | +302.44% |
| 2013 | 2013-12-31 | $2.0M | $2.0M | — |
| 2012 | 2012-12-31 | $0 | $0 | — |
| 2011 | 2011-12-31 | $0 | — | — |
SELLAS Life Sciences Group quarterly gross profit
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q4 2023 | 2023-12-31 | $0 | $0 | — |
| Q3 2023 | 2023-09-30 | $0 | $0 | — |
| Q2 2023 | 2023-06-30 | $0 | $0 | — |
| Q1 2023 | 2023-03-31 | $0 | −$900,000 | — |
| Q4 2022 | 2022-12-31 | $0 | $0 | — |
| Q3 2022 | 2022-09-30 | $0 | $0 | — |
| Q2 2022 | 2022-06-30 | $0 | −$1.8M | — |
| Q1 2022 | 2022-03-31 | $900,000 | −$4.7M | −83.93% |
| Q4 2021 | 2021-12-31 | $0 | −$1.9M | — |
| Q3 2021 | 2021-09-30 | $0 | $0 | — |
| Q2 2021 | 2021-06-30 | $1.8M | $1.8M | — |
| Q1 2021 | 2021-03-31 | $5.6M | $5.6M | — |
| Q4 2020 | 2020-12-31 | $1.9M | — | — |
| Q3 2020 | 2020-09-30 | $0 | — | — |
| Q2 2020 | 2020-06-30 | $0 | — | — |
| Q1 2020 | 2020-03-31 | $0 | — | — |
| Q2 2015 | 2015-06-30 | $2.9M | $930,000 | +46.88% |
| Q1 2015 | 2015-03-31 | $2.4M | $515,000 | +27.96% |
| Q4 2014 | 2014-12-31 | $2.7M | $1.5M | +121.07% |
| Q3 2014 | 2014-09-30 | $1.4M | −$81,000 | −5.57% |
| Q2 2014 | 2014-06-30 | $2.0M | −$930,000 | −31.91% |
| Q1 2014 | 2014-03-31 | $1.8M | −$515,000 | −21.85% |
| Q4 2013 | 2013-12-31 | $1.2M | $0 | 0.00% |
| Q3 2013 | 2013-09-30 | $1.5M | $1.5M | — |
| Q2 2013 | 2013-06-30 | $2.9M | $0 | 0.00% |
| Q1 2013 | 2013-03-31 | $2.4M | $0 | 0.00% |
| Q4 2012 | 2012-12-31 | $1.2M | — | — |
| Q3 2012 | 2012-09-30 | $0 | — | — |
| Q2 2012 | 2012-06-30 | $2.9M | — | — |
| Q1 2012 | 2012-03-31 | $2.4M | — | — |
SELLAS Life Sciences Group gross profit trends
Between the periods ended 2011-12-31 and 2023-12-31, SELLAS Life Sciences Group's gross profit increased from $0 to $0, a change of $0. The latest reported quarter, Q4 2023, shows $0.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review SELLAS Life Sciences Group source filings ↗